Cantor Fitzgerald’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Cantor Fitzgerald’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-368,606	Closed	-$3.78M	–	681
2023 Q2	$3.78M	Hold	368,606	–	–	0.09%	216
2023 Q1	$3.73M	Hold	368,606	–	–	0.08%	260
2022 Q4	$3.68M	Buy	368,606 +90,019	+32%	+$886K	0.08%	270
2022 Q3	$2.71M	Buy	278,587 +113,753	+69%	+$1.11M	0.06%	303
2022 Q2	$1.6M	Buy	+164,834	New	+$1.6M	0.03%	396

Cantor Fitzgerald's DALS Position: Q3 2023 in Review

Cantor Fitzgerald sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 368,606 shares — an estimated $3.78M sold.

Cantor Fitzgerald first reported a position in DALS in Q2 2022 and held it in 5 quarters. The position peaked at $3.78M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Cantor Fitzgerald reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Cantor Fitzgerald sold 368,606 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $3.78M.
Cantor Fitzgerald first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 5 quarters.
Cantor Fitzgerald's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $3.78M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Cantor Fitzgerald's 13F filing for Q3 2023, filed 14 Nov 2023.